Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis. [electronic resource]
- Clinical neurology and neurosurgery Jul 2008
- 718-21 p. digital
Publication Type: Case Reports; Journal Article
0303-8467
10.1016/j.clineuro.2008.03.008 doi
Adult Antiparkinson Agents--therapeutic use Cerebral Ventricles--pathology Humans Hydrocephalus--etiology Levodopa--therapeutic use Male Neurocysticercosis--complications Parkinsonian Disorders--drug therapy Ventriculoperitoneal Shunt--adverse effects